Publications by authors named "Amy Whitworth"

Claim this Profile
A
A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients.
Wen Wee Ma, Hao Xie, Gerald Fetterly, Laura Pitzonka, Amy Whitworth

Am J Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events.
Sidra Anwar, Wei Tan, Chi-Chen Hong, Sonal Admane, Askia Dozier, Amy Whitworth

Cancers (Basel)· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer.
Wen Wee Ma, Wells A Messersmith, Grace K Dy, Colin D Weekes, Amy Whitworth

Clin Cancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with chronic lymphocytic leukemia treated with lenalidomide.
Kena C Miller, Laurie Musial, Amy Whitworth, Asher Chanan-Khan

Clin J Oncol Nurs· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics.
Taimur Sher, Kena C Miller, David Lawrence, Amy Whitworth, Francisco Hernandez-Ilizaliturri

Leuk Lymphoma· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemia.
Asher A Chanan-Khan, Amy Whitworth, Naveen Bangia, Carl W Porter, Kelvin Lee

J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis